STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

about

Signal Transducer and Activator of Transcription 3 Control of Human T and B Cell Responses.Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation.

P2860

Q50301153-E2ED3880-1261-49E6-B95C-A3AD8A163242 Q55191226-5A6B167A-A741-487D-8860-AF32538B09C2

P2860

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

Item

http://www.wikidata.org/entity/Q42038683

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

@en

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

@nl

type

Item

label

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

@en

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

@nl

prefLabel

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

@en

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

@nl

P1476

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

@en

P2093

Aline Moignet

http://www.w3.org/2001/XMLSchema#string

Anna Cabrelle

http://www.w3.org/2001/XMLSchema#string

Antonella Teramo

http://www.w3.org/2001/XMLSchema#string

Chiara Ercolin

http://www.w3.org/2001/XMLSchema#string

Cristina Gattazzo

http://www.w3.org/2001/XMLSchema#string

Cédric Pastoret

http://www.w3.org/2001/XMLSchema#string

Elena De March

http://www.w3.org/2001/XMLSchema#string

Elisa Boscaro

http://www.w3.org/2001/XMLSchema#string

Elisa Pagnin

http://www.w3.org/2001/XMLSchema#string

Francesco Piazza

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutations in hairy-cell leukemia

Somatic STAT3 mutations in large granular lymphocytic leukemia

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Clinical features of large granular lymphocyte leukemia

The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis

Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.

Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)

The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.

Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.

P304

61876-61889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18711

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28977911

http://www.w3.org/2001/XMLSchema#string

P932

5617471

http://www.w3.org/2001/XMLSchema#string

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

about

P2860

P2860

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932